Bridgewater Associates LP Has $382,000 Stock Position in CorVel Co. (NASDAQ:CRVL)

Bridgewater Associates LP lowered its stake in shares of CorVel Co. (NASDAQ:CRVL - Free Report) by 57.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 3,429 shares of the business services provider's stock after selling 4,722 shares during the period. Bridgewater Associates LP's holdings in CorVel were worth $382,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. Vanguard Group Inc. lifted its stake in shares of CorVel by 202.1% during the fourth quarter. Vanguard Group Inc. now owns 3,281,649 shares of the business services provider's stock worth $365,116,000 after purchasing an additional 2,195,466 shares in the last quarter. Renaissance Technologies LLC boosted its position in CorVel by 184.1% in the 4th quarter. Renaissance Technologies LLC now owns 1,858,830 shares of the business services provider's stock valued at $206,813,000 after buying an additional 1,204,611 shares during the last quarter. Neuberger Berman Group LLC grew its stake in shares of CorVel by 204.6% during the fourth quarter. Neuberger Berman Group LLC now owns 845,531 shares of the business services provider's stock valued at $94,074,000 after acquiring an additional 567,984 shares in the last quarter. Geode Capital Management LLC increased its position in shares of CorVel by 205.1% during the fourth quarter. Geode Capital Management LLC now owns 774,653 shares of the business services provider's stock worth $86,204,000 after acquiring an additional 520,783 shares during the last quarter. Finally, Boston Trust Walden Corp lifted its stake in shares of CorVel by 196.8% in the fourth quarter. Boston Trust Walden Corp now owns 690,053 shares of the business services provider's stock worth $76,775,000 after acquiring an additional 457,538 shares in the last quarter. 51.36% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at CorVel

In other news, Director Steven J. Hamerslag sold 10,000 shares of the company's stock in a transaction dated Thursday, February 6th. The stock was sold at an average price of $123.48, for a total value of $1,234,800.00. Following the transaction, the director now owns 314,000 shares in the company, valued at $38,772,720. This represents a 3.09 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Alan Hoops sold 10,200 shares of the business's stock in a transaction on Tuesday, February 18th. The shares were sold at an average price of $116.39, for a total transaction of $1,187,178.00. Following the transaction, the director now owns 118,213 shares in the company, valued at approximately $13,758,811.07. This represents a 7.94 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 48,723 shares of company stock worth $5,757,140. 47.57% of the stock is owned by company insiders.

CorVel Price Performance

Shares of NASDAQ:CRVL traded down $3.47 during midday trading on Thursday, reaching $111.17. The company had a trading volume of 478,143 shares, compared to its average volume of 116,737. The stock has a market capitalization of $5.71 billion, a P/E ratio of 65.39 and a beta of 0.94. The stock's fifty day moving average price is $110.88 and its 200-day moving average price is $115.45. CorVel Co. has a one year low of $76.53 and a one year high of $128.61.

CorVel (NASDAQ:CRVL - Get Free Report) last released its earnings results on Tuesday, February 4th. The business services provider reported $0.46 earnings per share for the quarter. CorVel had a net margin of 10.12% and a return on equity of 32.22%.

Analyst Ratings Changes

Separately, StockNews.com upgraded CorVel from a "hold" rating to a "buy" rating in a research note on Friday, April 18th.

CorVel Profile

CorVel Corporation provides workers' compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.